Blackline Inc: “It’s enterprise software that’s losing money. Those are the ones I’m trying to get people to stay away from.”
Piedmont Lithium Inc: “Much too dangerous. Way too speculative. We’re going to take a pass on that one.”
Bloom Energy Corp: “They’re not working. They’re too expensive. I want you to avoid Bloom Energy.”
Oramed Pharmaceuticals Inc: “This thing has had way too big a move. I can not get behind it. It’s way too speculative.”
Disclaimer: Cramer’s Charitable Trust owns shares of Eli Lilly.
